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clinical applications exemplified. Finally, future directions will be 
discussed.  
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Cone beam CT (CBCT) has been widely utilized for localizing daily 
tumor position and patient positioning in lung cancer radiotherapy. 
However, due to the respiratory motion during the CBCT scan, the 
tumor image is blurred and may introduce inaccuracy in treatment 
delivery. To solve this problem, and to obtain accurate daily lung 
tumor motion information, we have been developing cine CBCT 
technologies, either with or without prior images, to reconstruct a 
series of 3D CBCT images from a regular CBCT scan, corresponding to 
different breathing phases or time points during the scan. For the 
technology using prior images, we used 4DCT as training data. A 
deformable image registration is first carried out between among 
4DCT images resulting in deformation vector fields (DVFs). These DVFs 
are represented by a few eigenvectors and coefficients obtained from 
principal component analysis (PCA). The volumetric reconstruction 
from a CBCT projection is realized by optimizing the PCA coefficients 
such that the computed projection matches the measured CBCT 
projection. For the technology without prior images, we developed a 
novel algorithm to reconstruct  a 3D image corresponding to each 
CBCT projection, by effectively utilizing the underlying 
temporal coherence, such as periodicity or repetition, in all 
reconstructed 3D images. Assuming each column of the matrix U 
represents a CBCT image to be reconstructed and the total number of 
columns is the same as the number of projections, the central idea of 
our method is that U can be approximated well by a matrix whose 
rank is much smaller than the number of projections in the matrix 
factorization form U ≈ LR. The number of columns for the matrix L 
constraints the rank of approximation and hence implicitly imposing a 
temporal coherence condition among all the images in cine-CBCT. We 
further impose desired image properties by enforcing sparsity of 
the tight wavelet frame transform of L. In this matrix factorization 
formulation both the low rank approximation and the sparse 
representation in wavelet transform domain reduces the true degree 
of freedom of U significantly. A split Bregman method is used to solve 
the problem.  
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The standard treatment of locally advanced cervical cancer consists of 
external beam radiotherapy with concomitant cisplatin followed by 
intracavitary brachytherapy (BT). For decades BT has most often been 
based on radiographs with the BT dose prescribed to point A. 
In 2005 an adaptive target concept for BT based on 3D imaging was 
introduced by the GYN GEC-ESTRO working group addressing both the 
tumour extend at diagnosis – the Intermediate Risk Clinical Target 
Volume (IR CTV) as well as the remaining tumour at time of BT – the 
High Risk Clinical Target Volume (HR CTV).  
With the introduction of Image Guided Adaptive BT (IGABT) it is 
possible to move from point A to 3D dose volume prescription in terms 
of dose volume histogram (DVH) parameters. Furthermore, dose 
optimisation can be performed with modifications of standard loading 
patterns leading to an individually sculpted pear-shaped isodose 
tailored to the target and organs (OAR) at risk at time of BT. 
However, dose optimisation based on intracavitary (IC) BT applicators 
have limitations especially in large tumours with extensive 
parametrial involvement remaining at time of BT or in cases with 
unfavourable combination of topography between the HR CTV and the 
OAR. A solution is to add an interstitial (IS) component to the basic IC 
applicator. Studies with limited number of patients have shown that 
combined IC/IS BT improve the DVH parameters, but larger studies on 
clinical feasibility are sparse and widespread implementation of the 
IC/IS technique is so far limited. 
At present, promising mono-institutional data on IGABT for cervical 
cancer with high local control rates and limited morbidity have been 
published. Furthermore, several studies have established dose 
constrains for target as well as OAR.  
In order to achieve more experience on IGABT for cervical cancer, 
large-scale multi-studies such as the EMBRACE-study and 
RETROEMBRACE-study have been initiated. During the next years, data 
will mature for analysis and serve as benchmark for future IGABT in 
cervical cancer. 
The purpose of this lecture is to describe and explain the basic 
components behind the recommendations from the GYN GEC-ESTRO 
working group. Furthermore, it is aimed to review the literature on 
IGABT and describe outcome in terms of local control, survival and 
morbidity from published mono-institutional series of patients. 
Finally, it is aimed to describe the future directions in IGABT for 
cervical cancer. 
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For cervical cancer interstitial and intracavitary brachytherapy 
techniques are an option to treat the tumour sufficient by keeping the 
traditional pear-shaped isodose distribution. Improvement of target 
coverage and organs at risk sparing is determined by DVH parameters 
D90, D98 (D100) for the target and D2cc, D0.1cc for OAR. The major 
limitation in the optimization process is the dose to the adjacent 
OAR’s like sigmoid, rectum and bladder. As the pear-shaped dose 
distribution based on the intracavitary applicator can be enlarged to a 
certain extend only, additional needles are useful to push the isodose 
lines into the needed direction (Parametrium- pelvic side wall).  
The selection of the adequate application technique depends on the 
size and shape of the target volume at time of brachytherapy (after 
EBRT). With intracavitary techniques tumours which are limited to the 
cervix can be appropriately treated. Nevertheless, small tumours with 
unfavourable topographies within the pelvis (narrow anatomies with 
only a small distance from the tumour to the OAR bladder, rectum or 
sigmoid) may benefit from the use of additional needles. Over the last 
years “standard” intracavitary applicators have been modified in a 
way to allow insertion of needles through guiding holes, i.e. the 
“vaginal” part of the applicator (ring, ovoid or mould) serves as and 
interstitial template which is attached to the cervix. Other techniques 
use vaginal cylinders including oblique guiding holes or templates like 
the MUPIT or Syed. For vaginal cancer intravaginal templates exist. In 
interstitial treatment planning, traditionally, the Paris System rules 
are kept in mind. Different tools like inverse planning, graphical drag-
and-drop of isodose lines and other optimization techniques are 
available but should be handled with caution. The final dose 
distribution including high dose volumes should always be checked 
before irradiation. In situation of complex tumour configurations pre-
planning of the application technique with 3D imaging increases the 
quality of the implant and of the final treatment plan. 
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The BT Service, in terms of material, is composed of five pulsed dose 
rate (PDR) and one high dose rate (HDR) afterloaders. Interstitial, 
endocavitary and endoluminal BT are performed depending on the 
type and tumor localizations. The team consists of physicians, 
residents, medical physicists and radiation therapy technologists 
(RTTs). The presentation purpose is to describe the role and the work 
of an RTT in the treatment of patients with cervix cancers in our 
institute. 
Role of RTT: 
RTT plays a major role in a BT service. Essential for the team 
cohesion, she is working at the interface of the radiation oncologist, 
medical physicist, and patient. Present in all steps of the treatment, 
she participates to the consultation, preparation, implantation, 
dosimetry and treatment compliance. In order to improve the overall 
treatment conditions, a pre-therapeutic consultation is systematically 
performed by the RTT. The aim is to answer questions about 
hospitalization, radioactivity, management of pain and treatment 
itself. A picture book describing the different steps of the treatment 
was designed by RTT. This helps and allows a better understanding for 
patients. 
The technique used in our institute for the cervix BT consists of the 
vaginal mould technique. For each patient, a customized vaginal 
mould is created from a vaginal impression. The mould applicator 
